Wingate Wealth Advisors, Inc. Cor Medix Inc. Transaction History
Wingate Wealth Advisors, Inc.
- $112 Billion
- Q2 2025
A detailed history of Wingate Wealth Advisors, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Wingate Wealth Advisors, Inc. holds 129,537 shares of CRMD stock, worth $1.49 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
129,537
Previous 126,015
2.79%
Holding current value
$1.49 Million
Previous $776 Million
105.59%
% of portfolio
1.42%
Previous 0.89%
Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
162Shares Held
26.4MCall Options Held
475KPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.7 Million0.04% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.44MShares$28.1 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.6MShares$18.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $474M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...